SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elroy Jetson who wrote (100433)8/5/2009 9:28:46 PM
From: Casaubon  Read Replies (1) of 116555
 
Only because of this undue influence of large pharma does the large pharmaceutical industry enjoy a return on capital which is triple that of other American businesses.

If this statement were true, wouldn't it imply that the stock price appreciation of these companies were growing at 3x that of comparable companies?

Two implications from your flawed statement: The stocks are, in fact, not appreciating at a rate anywhere near what you imply.

If they were growing return on capital at such a prodigious rate, you could borrow massive sums (perhaps by leveraging up your house) and achieve unbelievable returns without risk.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News